폴라리스AI파마

041910KOSDAQ의약품 제조업

63.3 / 100

Reference Date: 2026-07-24

Financial Score17.0 / 40

News Sentiment21.3 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Surged 20.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Polaris AI Pharma primarily operates in API (Active Pharmaceutical Ingredient) and CDMO (Contract Development and Manufacturing Organization) sectors, with API contributing 96.3% of its 2025 revenue. The company focuses on expanding high-value CDMO services while maintaining strong collaborations with domestic and international pharmaceutical firms, particularly emphasizing exports to the demanding Japanese market.

Number of Employees

167people

Average Salary

51.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.09Industry Average 11.233.0Point

Higher than industry avg (caution)

PBR

0.55Industry Average 0.815.5Point

Lower than industry avg (good)

ROE

4.66Industry Average 4.014.0Point

In line with industry avg

Debt Ratio

22.92Industry Average 12.430.5Point

1.8x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼7.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲807.7% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.7% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
핸디소프트·폴라리스오피스, 캠코 차세대 그룹웨어 구축 완료
폴라리스오피스의 기술이 핸디소프트의 차세대 그룹웨어 시스템 구축에 성공적으로 통합되어 폴라리스AI파마의 기술적 파트너십이 강화되었다.

Detailed Momentum

52-week position3.0Point

52w lower range (28%)

Current 5,610Won52-week high 8,92052-week low 4,300

1-month return6.0Point

1m +20.78% (strong rise)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-07-10